Skip to main navigation

Skip to content

Newsroom
Join our team

About us
Our purpose
Our culture
Products & pipeline
Investors

About us
Our purpose
Our culture
Products & pipeline
Investors

Newsroom
Join our team

About us
Our purpose
Our culture
Products & pipeline
Investors

Newsroom
Join our team

Dashboard
Press releases
Quarterly results
Financials & filings
Events & presentations
Stock information
Analyst coverage
Corporate governance
Investor FAQs

Search for:

Press releases

Press releases

Year

Adamas to Present at Upcoming Needham Conference

April 7, 2021

Adamas publishes new data analyses demonstrating GOCOVRI treatment more than doubled ON time without dyskinesia in patients with Parkinson’s disease

March 29, 2021

Adamas Announces New Employment Inducement Grant

March 5, 2021

Adamas Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

March 1, 2021

Adamas Pharmaceuticals Announces Pricing of Follow-on Public Offering

February 24, 2021

Adamas Pharmaceuticals Announces Launch of Follow-on Public Offering

February 24, 2021

Adamas Reports Fourth Quarter and Full Year 2020 Financial Results

February 23, 2021

Adamas to Present at Upcoming Healthcare Conferences

February 17, 2021

Adamas to Announce Fourth Quarter and Year-End 2020 Financial Results and Host Conference Call on February 23, 2021

February 10, 2021

Adamas Announces FDA Approval for Second Indication for GOCOVRI® as an Adjunctive Treatment to levodopa/carbidopa in Parkinson’s Disease Patients Experiencing OFF Episodes

February 1, 2021

Pagination

Current page 1
Page 2
Next page
Last page

Quick links

Email alerts
Quarterly results

Annual reports
Investor contact

Connect with us

Contact us
Privacy policy
Online tracking opt-out guide
Terms of use
Site map

© 2021 Copyright Adamas Pharmaceuticals, Inc. or its related companies. All rights reserved.

© 2021 Copyright Adamas Pharmaceuticals, Inc. or its related companies. All rights reserved.